Evidence map›Paper›PMID 36977580›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Margot P Wohl, Jett Liu, Kenta Asahina

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Cell type-specific driver lines targeting thebioRxiv : the preprint server for biology · 2025
    Article
  11. Sleep deprivation drives brain-wide changes in cholinergic presynapse abundance inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Margot P WohlSalk Institute for Biological Studies, La Jolla, California 92037.
Jett LiuSalk Institute for Biological Studies, La Jolla, California 92037.
Kenta AsahinaSalk Institute for Biological Studies, La Jolla, California 92037 kasahina@salk.edu.ORCID 0000-0001-6359-4369
Salk Institute for Biological Studies · US

Funding

Peptidergic neuromodulation of microcircuits that control chemosensation-induced behaviorsR01DC015577 · NIDCD · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI KENTA ASAHINA · 2017 to 2026
$4.1M
NIDCD NIH HHS R01 DC015577
6 · The paper itself

Abstract

Neuropeptides influence animal behaviors through complex molecular and cellular mechanisms, the physiological and behavioral effects of which are difficult to predict solely from synaptic connectivity. Many neuropeptides can activate multiple receptors, whose ligand affinity and downstream signaling cascades are often different from one another. Although we know that the diverse pharmacological characteristics of neuropeptide receptors form the basis of unique neuromodulatory effects on distinct downstream cells, it remains unclear exactly how different receptors shape the downstream activity patterns triggered by a single neuronal neuropeptide source. Here, we uncovered two separate downstream targets that are differentially modulated by tachykinin, an aggression-promoting neuropeptide in

Indexed as

DrosophilaNeuropeptidesAggressionAnimalsHumansMaleNeuronsReceptors, NeuropeptideTachykininsNeuropeptidesReceptors, NeuropeptideTachykininsaggressionDrosophilaG-protein-coupled receptorneuromodulationneuropeptidetachykinin

Identifiers

PMID36977580
PMCPMC10184743
OpenAlexW4361212817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.